# Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol

Study · id `cardio:ct-nct02098772` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02098772](<https://clinicaltrials.gov/study/NCT02098772>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02098772

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 530 participants.

## Technical summary

Registry record NCT02098772. Randomized; double masking; primary purpose treatment. Start 2014-05 (actual); primary completion 2018-11-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 530 participants (enrolled count; ClinicalTrials.gov record NCT02098772, source copy `cardio:ctgov-nct02098772-2020-01-18`, retrieved 2026-10-26)
- Started: 2014-05 (actual) (ClinicalTrials.gov record NCT02098772, source copy `cardio:ctgov-nct02098772-2020-01-18`, retrieved 2026-10-26)
- Primary completion: 2018-11-16 (actual) (ClinicalTrials.gov record NCT02098772, source copy `cardio:ctgov-nct02098772-2020-01-18`, retrieved 2026-10-26)
- Completion: 2018-12 (actual) (ClinicalTrials.gov record NCT02098772, source copy `cardio:ctgov-nct02098772-2020-01-18`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02098772, source copy `cardio:ctgov-nct02098772-2020-01-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02098772-2020-01-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol
- Acronym: Custodiol-AV
- Condition: Aortic Valve Disease
- Condition: Coronary Artery Disease (CAD)
- Intervention (Drug): Custodiol-N
- Intervention (Drug): Custodiol
- Lead sponsor: Dr. F. Köhler Chemie GmbH
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Dr. F. Köhler Chemie GmbH (`cardio:org-dr-f-kohler-chemie-gmbh`)

## Provenance

Content hash: 55ad7cd03d7aa055c227852746c5be793f7ed8aaab015eb110fb7ae14ee98dd4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
